Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (571-580 of 600) with videos related to

Pageof 60
Sort By:
European Journal of Heart Failure|December 3, 2020
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Thrombosis and Haemostasis|August 6, 2019
Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque InstabilityPhilipp Diehl, Frederik Nienaber, Maria T K Zaldivia, et al.
Thrombosis and Haemostasis|November 18, 2016
Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO)Dennis Wolf, Nora Bukosza, David Engel, et al.
Circulation|December 28, 2018
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil DegranulationMaximilian Mauler, Nadine Herr, Claudia Schoenichen, et al.
Circulation Research|January 24, 2018
Inflammatory Pathways Regulated by Tumor Necrosis Receptor-Associated Factor 1 Protect From Metabolic Consequences in Diet-Induced ObesityNathaly Anto Michel, Christian Colberg, Konrad Buscher, et al.
Circulation Research|October 15, 2011
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in miceDennis Wolf, Jan-David Hohmann, Ansgar Wiedemann, et al.
American Heart Journal|October 16, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarctionC Michael Gibson, John J P Kastelein, Adam T Phillips, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
Basic Research in Cardiology|March 15, 2021
A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarctionPatrick M Siegel, István Bojti, Nicole Bassler, et al.
Pageof 60

Showing results (571-580 of 600) with videos related to

Sort By:
Pageof 60
European Journal of Heart Failure|December 3, 2020
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Thrombosis and Haemostasis|August 6, 2019
Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque InstabilityPhilipp Diehl, Frederik Nienaber, Maria T K Zaldivia, et al.
Thrombosis and Haemostasis|November 18, 2016
Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO)Dennis Wolf, Nora Bukosza, David Engel, et al.
Circulation|December 28, 2018
Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil DegranulationMaximilian Mauler, Nadine Herr, Claudia Schoenichen, et al.
Circulation Research|January 24, 2018
Inflammatory Pathways Regulated by Tumor Necrosis Receptor-Associated Factor 1 Protect From Metabolic Consequences in Diet-Induced ObesityNathaly Anto Michel, Christian Colberg, Konrad Buscher, et al.
Circulation Research|October 15, 2011
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in miceDennis Wolf, Jan-David Hohmann, Ansgar Wiedemann, et al.
American Heart Journal|October 16, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarctionC Michael Gibson, John J P Kastelein, Adam T Phillips, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
Basic Research in Cardiology|March 15, 2021
A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarctionPatrick M Siegel, István Bojti, Nicole Bassler, et al.
Pageof 60